Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Cti Biopharma Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +28 vs. Q1 2022
- Shares held
- 88.5M
- +29.1M (+49.1%) vs. Q1 2022
- Total value
- $510.1M
- +$166.3M (+48.4%) vs. Q1 2022
- New holders
- 47
- 38 more added
- Sold out
- 19
- 21 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 2 | $474.2K |
| Q1 2023 | 133 | $475.2M |
| Q4 2022 | 145 | $619.8M |
| Q3 2022 | 133 | $554.7M |
| Q2 2022 | 119 | $510.1M |
| Q1 2022 | 92 | $344.9M |
| Q4 2021 | 63 | $118.3M |
| Q3 2021 | 56 | $159.6M |
| Q2 2021 | 50 | $133.1M |
| Q1 2021 | 55 | $126.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cti Biopharma Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1,171,774 | $7.00M | 0.00% | +1,167,902+30,162.8% | Added |
| Verition Fund Management LLC | 1,284,325 | $7.67M | 0.17% | +289,045+29.0% | Added |
| Invesco Ltd. | 1,379,906 | $8.24M | 0.00% | −23,708−1.7% | Reduced |
| Silverarc Capital Management, LLC | 1,380,111 | $8.24M | 3.86% | −869,889−38.7% | Reduced |
| Two Sigma Investments, LP | 1,399,372 | $8.35M | 0.03% | −419,590−23.1% | Reduced |
| Wellington Management Group LLP | 1,533,470 | $9.15M | 0.00% | +1,533,470 | New |
| Geode Capital Management, LLC | 1,588,547 | $9.48M | 0.00% | +810,931+104.3% | Added |
| Nuveen Asset Management, LLC | 1,750,193 | $10.4M | 0.00% | +1,750,193 | New |
| Fairmount Funds Management LLC | 2,245,891 | $13.4M | 3.07% | +2,245,891 | New |
| Lion Point Capital, LP | 5,489,546 | $14.5M | 5.13% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,704,510 | $16.1M | 1.44% | +751,819+38.5% | Added |
| Millennium Management LLC | 3,168,087 | $18.9M | 0.02% | +989,524+45.4% | Added |
| Stonepine Capital Management, LLC | 3,681,195 | $22.0M | 10.23% | −1,003,209−21.4% | Reduced |
| Bleichroeder LP | 3,948,730 | $23.6M | 4.87% | +89,023+2.3% | Added |
| Vanguard Group Inc | 4,376,439 | $26.1M | 0.00% | +777,024+21.6% | Added |
| BlackRock Inc. | 5,890,969 | $35.2M | 0.00% | +4,099,276+228.8% | Added |
| NEA Management Company, LLC | 8,047,228 | $48.0M | 2.47% | +906,778+12.7% | Added |
| BVF Inc | 8,929,690 | $53.3M | 2.57% | 00.0% | Unchanged |
| State Street Corp | 9,849,528 | $58.8M | 0.00% | +9,578,193+3,530.0% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −862,383−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −299,800−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −171,161−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −162,309−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −80,916−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −71,918−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −47,182−100.0% | Sold out |
| Bartlett & Co. Wealth Management LLC | 0 | $0 | 0.00% | −36,500−100.0% | Sold out |
| Bartlett & Co. LLC | 0 | $0 | 0.00% | −36,500−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −32,359−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −30,499−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,472−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −15,571−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −12,663−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −445−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Bedel Financial Consulting, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |